NCT06953661View on ClinicalTrials.gov

Ultrasound Guided Stellate Ganglion Block in Postural Tachycardia Syndrome

NANot yet recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 13, 2025

Primary Completion Date

November 30, 2026

Study Completion Date

November 30, 2026

Conditions
Postural Tachycardia Syndrome
Interventions
PROCEDURE

Stellate ganglion block

Patients will receive a SGB

PROCEDURE

Sham injection of saline

Patients will receive a subcutaneous sham injection of saline

DRUG

Ropivacaine

The SGB group will receive ropivacaine 0.5% 10ml

DRUG

Normal saline

The control group will receive normal saline in the sham injection.

Trial Locations (2)

94304

Stanford University School of Medicine, Stanford

94305

Stanford University, Stanford

All Listed Sponsors
lead

Stanford University

OTHER

NCT06953661 - Ultrasound Guided Stellate Ganglion Block in Postural Tachycardia Syndrome | Biotech Hunter | Biotech Hunter